FreeCE.com Catalog of Homestudy CE Programs

NS3/4A Protease Inhibitors: Treatment Options for Chronic Hepatitis Genotype 1

Mon, 30 Apr 2012 00:00:00 GMT

At the completion of this activity, the participants will be able to understand the epidemiology and basic life cycle of hepatitis C virus and explain the mechanism action, dosing and role of NS3/4A protease inhibitors for chronic hepatitis C. Participants will know how to discuss the role and appropriate duration of use of NS3/5A protease inhibitors for naive and previously treated patients. Participants will also be able to understand the differences between treatment regimens for boceprevir and telaprevir. Lastly, participants will know how to interpret laboratory results to make determinations of treatment duration or futility and recognize and manage prominent adverse events associated with treatment.

Contrast Agents for Diagnostic Imaging - What Pharmacists Need to Know

Tue, 01 May 2012 00:00:00 GMT

Most schools of pharmacy do not cover the area of diagnostic imaging to any appreciable extent in the cirriculum, so very few practicing pharmacists have a high level of comfort when dealing with issues relating to diagnostic imaging. This program provides an overview of clinically relevant information for the imaging-related medications commonly in use. It reviews the safety improvements in new generations of drugs; risk factors and precautions for the reduction of severe adverse reactions; and the significance of diligent patient screening before contrast exposure and appropriate monitoring after exposure.

A Sinister Trinity: The Cyclical Relationship Between Sleep, Pain and Opioids

Wed, 15 Feb 2012 00:00:00 GMT

This program will provide health care professionals with an understanding of sleep dysfunction and pain. After completing this program, participants will be able to recognize the prevalence and impact of chronic pain and co-morbid sleep dysfunction. Participants will then be able to identify and describe the mechanisms responsible for the bi-directional relationship between pain and sleep. Next, the program will provide health care providers to be able to describe the impact of opioid therapy on pain and sleep and assess and diagnose sleep dysfunction in the context of chronic pain and opioid therapy. Finally, participants will know how to manage both chronic pain and co-morbid sleep dysfunction with an appropriate intervention which maximizes pain relief while minimizing sleep related adverse events

The Pathophysiology and Pharmaceutical Treatment of Gastric Ulcers

Thu, 08 Mar 2012 00:00:00 GMT

This program will provide participants with an understanding of pathophysiological and pharmaceutical treatments of gastric ulcers. After completing this program, participants will be able to understand the pathophysiology, incidence, and prevalence of gastric ulceration. Participants will also be able to list primary symptoms and main risk factors of gastric ulceration. Lastly, participants will be able to identify the most commonly used pharmaceuticals and their potential side effects.

Diabetes: The Patient

Mon, 14 May 2012 00:00:00 GMT

The fourth presentation in a four-part series will provide an opportunity for the application of all that has been learned in the previous presentations to a patient case. This participant will evaluate, modify, develop, and monitor an optimal diabetes management plan for a complicated patient with diabetes. The role of the pharmacist on the healthcare team of a patient with diabetes will also be addressed.

Relieving Frequent Heartburn - Day through Night

Wed, 14 Jul 2010 00:00:00 GMT

50 million Americans are estimated to have frequent heartburn, defined as symptoms occurring at least 2 days / week. Many of these sufferers experience nighttime symptoms, which are often associated with a higher rate of complications. Most episodes of nighttime reflux occur during the first few hours of sleep and lead to a broken sleep pattern. This can result in daytime fatigue, affecting quality of life and work productivity. Many heartburn sufferers seek the advice of their pharmacist on how they should best relieve their symptoms. Frequent heartburn can be treated effectively over the 24 hour dosing interval with a once daily PPI given OTC. This knowledge based webinar aims to provide pointers on who is at risk of frequent heartburn, what questions to ask to diagnose heartburn and recognize nighttime symptoms, and how to decide who is appropriate for OTC PPI treatment and who should be recommended to see their physician. The webinar includes a case scenario to provide an opportunity to discuss many of the key issues relating to the management of frequent heartburn with nighttime breakthrough.

Benign Prostatic Hyperplasia (BPH) - When Bigger is Not Better

Mon, 28 Nov 2011 00:00:00 GMT

This program will provide nurses and pharmacists with an understanding of benign prostatic hyperplasia (BPH). After the completion of the program, participants will be able to define BPH and its causes. Next, participants will know how to describe two minimally invasive treatments for BPH as well as describe surgical procedures used to treat BPH. Finally, health care professionals will be able to identify two medications and their side effects used to treat BPH.

Help for the Pain - The Pharmacist's Role in Treating Fibromyalgia

Thu, 21 Jan 2010 00:00:00 GMT

Pharmacists can play a key role in alleviating the shortcomings and the misunderstanding about fibromyalgia. They can provide valuable counseling on topics such as lifestyle modifications and treatment options for fibromyalgia. Simple changes can often lead to considerable symptom improvement. Once fibromyalgia has been diagnosed, the pharmacist can provide counseling about managing comorbidities, drug contraindications, and general safety issues.

Combination Antiretroviral Treatment Options: The Advent of Fixed-Dose Regimen Simplification

Thu, 01 Mar 2012 00:00:00 GMT

This program will provide nurses and pharmacists an understanding of antiretroviral treatments. After completing the program, participants will be able to identify the CD4 counts and viral load levels that indicate the need for treatment initiation or revision. Secondly, participants will be able to outline the roles of resistance and adherence in selecting appropriate combination regimens. After completing the program, health care providers will also be able to describe which combinations are preferred agents and for whom. Lastly, participants will be able to differentiate the use of fixed-dose formulations from antiretroviral regimens with high pill burdens, including a discussion of where the newest agent, Complera, might fit into a treatment plan.

Current Management of Gestational Diabetes Mellitus

Fri, 20 May 2011 00:00:00 GMT

This program will provide participants with an understanding current management methods and strategies for Gestational Diabetes Mellitus. After completing this program, pharmacists and nurses will be able to describe Gestational Diabetes Mellitus and its potential adverse consequences to the mother and the baby. Pharmacists and nurses will be able to know to review the new criteria recommended by the American Diabetes Association for the diagnosis of Gestational Diabetes Mellitus and identify the current therapy recommendations for Gestational Diabetes Mellitus. Pharmacy technicians will be able to in general terms, describe the signs and symptoms of Gestational Diabetes. They will also be able to outline the potential adverse consequences of Gestational Diabetes Mellitus to the mother and baby.

The Pathophysiology and Pharmaceutical Treatment of Atherosclerosis

Tue, 03 Jan 2012 00:00:00 GMT

This program will provide participants with an understanding of pathophysiological pharmaceutical treatments of atherosclerosis. After completing this program participants will be able to describe the etiology and epidemiology of atherosclerosis and identify the risk factors associated with atherosclerosis. Participants will also know how to compare and contrast the pharmaceutical treatments for the major risk factors associated with atherosclerosis.

Treatment Options for Pneumonia Across the Age Spectrum

Tue, 20 Sep 2011 00:00:00 GMT

This program will provide participants with an understanding of pneumonia in a variety of age groups as well as the risks each of those groups suffer. After completing this program, participants will be able to identify the most likely pathogens that cause pneumonia. Participants will also be able to describe the appropriate antibiotic treatment for pneumonia in the following age groups: newborns, infants/toddlers/preschoolers, school age children, teens, adults, and seniors.

Treating Health Conditions During Pregnancy: Safety of Nonprescription Agents for Upper Respiratory and Gastric Complaints

Tue, 24 Jan 2012 00:00:00 GMT

This program will provide participants with an understanding of health conditions during pregnancy. After completing this program, participants will be able to discuss over-the-counter treatment options for the most common cold and allergy symptoms experienced during pregnancy. Participants will also know how to provide safe treatment options in the antacid and H2 receptor antagonist drug classes for reflux, specifying in the safest timing of use to minimize teratogenic risks. Lastly, participants will be able to prepare a list of OTC agents for constipation that are not preferred during pregnancy and use drug mechanisms and adverse event data to explain your reasoning.

Suffering in Silence- Women and Urinary Incontinence

Thu, 28 Jun 2012 00:00:00 GMT

At the completion of this activity, the participant will be able to outline the prevalence of urinary incontinence (highlighting women) and the significant barriers to treatment. Participants will also be able to describe the different treatment options for UI in patients with overactive bladder (OAB) including conservative, behavioral and pharmaceutical management. Lastly, participants will be able to outline the pharmacist's role in identifying and treating UI to include improving patient identification, adherence and outcomes.

Pharmacist technicians will be able to describe the barriers to treatment

Review of Federal Law for Pharmacy Technicians

Thu, 14 Feb 2013 00:00:00 GMT

This program will assist pharmacy technicians to understand the federal laws applicable to pharmacy. Topics covered include package inserts, dispensing controlled substances and schedule II controlled substances . The information in the monograph is based on the Federal Law and the Federal Controlled Substance Act. Some of the information may be different in different states. States can make their own laws more restrictive than federal law, but not less restrictive. All questions regarding the practice of pharmacy should be directed to a pharmacist or the Board of the Pharmacy in the state where the technician works.

The Pathophysiology and Pharmaceutical Treatment of Gout

Fri, 16 Dec 2011 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding of the pathophysiology and pharmaceutical treatment of gout. After completing this program, participants will be able to understand the prevalence and incidence of gout. Participants will also be able to list pathophysiology, primary symptoms and main risk factors. Lastly, participants will be able to identify the most commonly used pharmaceuticals and their potential side effects.

Diabetic Peripheral Neuropathy - A Painful Complication

Wed, 15 Dec 2010 00:00:00 GMT

Neuropathy is a common microvascular complication affecting nearly 50% of patients with diabetes. Complications from diabetic neuropathy account for 50% to 75% of nontraumatic amputations. The total annual cost of diabetic neuropathy and its complications in the United States is estimated to be between $4.6 and $13.7 billion. Pharmacists in all healthcare settings play an important role in the prevention and treatment of diabetic neuropathy.

Emily's Law Revisited: The Pharmacist, The Family, and the Medication Error that Changed Their Lives -LAW-

Wed, 15 May 2013 00:00:00 GMT

This presentation reviews the effect of a tragic medication error on the lives of the two victims, patient Emily Jerry and pharmacist Eric Cropp. Over the span of four years since the incident, much has changed in the lives of the families involved and in the practice of pharmacy. This compelling and emotional presentation is presented by Eric Cropp and Chris Jerry. This is the sequel to "Emily's Act: Impact on Public Safety and Medication Errors", which many participants stated was the most moving continuing education program they have ever attended.

ATTENTION FLORIDA Pharmacists and Technicians: This one hour presentation does NOT satisfy the medication errors requirement for the State of Florida.

Classes of Medication for Depression and Key Counseling Points

Tue, 18 Oct 2011 00:00:00 GMT

The role of pharmacists in the treatment of depression can be a key role. Pharmacists must understand not only the etiology of depression, but also the available treatment options. These treatment options include: standard doses, possible side effects, off-label uses of medications, medical emergencies, and educating patients and their families about common medications and treatments. After completing this program, participants will be able to review the etiology of depression including current thinking about causes of depression as well as review how mental health providers assess patients in order to optimize the best chance of medication compliance. Next, participants will be able to assess the current treatments for depression, including non-pharmacological treatments and the side effects of common anti-depressants in order to provide patients with this information.

Diabetes: The Basics

Tue, 27 Mar 2012 00:00:00 GMT

The first presentation in a four-part series will establish a foundation for the remainder of the presentations. This program will review the diagnostic criteria, screening criteria, societal and economic importance, and the co-morbidities and complications of diabetes. The focus of the presentation will be on evidence-based information related to these topics.

Diabetes: The Pearls

Fri, 13 Apr 2012 00:00:00 GMT

The third presentation in a four-part series will provide information and tips for managing patients with diabetes. Each patient with diabetes has individual characteristics that affect goals, treatment choices, and outcomes. Practical tips and tools to achieve the greatest possible outcome for each patient will be presented.

OTC-ORAL: A Review of Over-the-Counter Oral Dosage Forms

Thu, 27 Jan 2011 00:00:00 GMT

This program will provide pharmacists, technicians, and nurses with an overview of OTC medications and identify techniques for OTC counseling and patient consultation. The goal of this program is to educate fellow healthcare professionals regarding the selection process of appropriate over-the-counter medications.

I've Got a Secret: Identifying and Treating Urinary Incontinence in the Elderly

Thu, 01 Sep 2011 00:00:00 GMT

I’ve got a secret …Or keeping her secret should not be Maxine’s first and foremost concern when out shopping with the grand kids. When she visits the pharmacy in search of adult incontinence briefs, are you ready to help her with her bladder control issues? As frontline providers, pharmacists can help patients cope with this debilitating and embarrassing disorder. This program will educate pharmacists on barriers to diagnosis and treatment of urinary incontinence, treatment options and strategies to engage and to counsel patients about urinary incontinence

Risks Associated with Testosterone Replacement Therapy: A Safety Review

Thu, 16 Dec 2010 00:00:00 GMT

This program is designed to assist pharmacists, nurses, and nurse practitioners to better understand the potential risks associated with testosterone replacement therapy. Health care professionals will be updated on available testosterone treatment therapies. The program includes information on pharmacologic treatments, drug interactions, patient counseling, and safety risks.

Treatment Guidelines for Acute Coronary Syndrome

Thu, 10 Jan 2013 00:00:00 GMT

At the completion of this activity, the participant will be able to describe the evidence and guideline-based role of antiplatelet therapy in the prevention of coronary attacks in patients with acute coronary syndromes (ACS). Participants will also be able to compare and contrast the safety and efficacy of oral antiplatelet therapies for long-term prevention of coronary attacks in ACS patients to include bleeding risks associated with antiplatelet therapy. Lastly, participants will know how to describe the pharmacist's role in counseling patients to increase understanding of treatment guidelines and medication adherence as a critical component of long-term maintenance of ACS patients

Understanding and Treating Bipolar Disorder

Tue, 18 Dec 2012 00:00:00 GMT

Pharmacists can play a pro-active role in the treatment of bipolar disorder and the adherence problems associated with the illness. Pharmacist's must understand the underlying condition, potential of currently available and emerging treatment options (along with their probable results and possible side effects) and understand the need to educate patients and family members on drug treatment strategies and the long-term medication and adherence problems commonly encountered with bipolar patients.

A Tale of Two Patients- A Pharmacist's Role in Treatment of HIV -FL APPROVED-

Thu, 28 Jul 2011 00:00:00 GMT

CDC estimates that more than one million people are living with HIV in the United States. One in five of those people living with HIV is unaware of their infection. Despite increases in the total number of people living with HIV in the US in recent years, the annual number of new HIV infections has remained relatively stable. However, new infections continue at far too high a level, with an estimated 56,300 Americans becoming infected with HIV each year. More than 18,000 people with AIDS still die each year in the US. This knowledge based program will educate pharmacists in HIV treatment principles and current guidelines for use of antiretroviral therapy and offer insights into how pharmacists can make a difference in treatment outcomes. This program is Florida BOP approved for HIV.

Modifying the Progression of Atherosclerosis

Fri, 01 Apr 2011 00:00:00 GMT

This program will review recent developments in the understanding of how statins modify the progression of atherosclerosis, describe the clinical benefits and limitations of statin therapy and outline the clinical evidence that has shaped today’s concepts of cholesterol management. The pharmacist must understand the potential of currently available therapies (along with their probable results and possible side effects) and play an active role in educating patients on their strategies for modifying the progression of atherosclerosis.

Type 2 Diabetes: Challenges in Care for Hispanic Americans

Mon, 02 Jul 2012 00:00:00 GMT

Nearly 26 million Americans have diabetes. Overall, minority groups bear a disproportionate burden of this epidemic. The prevalence of diabetes in Hispanic Americans, both diagnosed and undiagnosed, is about 70 to 80 percent higher than that of non-Hispanic whites. Due to the rapidly growing number of Hispanics in many areas of the United States, pharmacists must be aware of common communication and cultural barriers that exist between the medical community and Hispanic patients.

Antioxidants 101

Mon, 14 Mar 2011 00:00:00 GMT

Roughly 10,000 chemicals in food act as antioxidants. Essential nutrients such as vitamins and minerals also function as antioxidants. Our bodies also produce several antioxidants. This program provides information on the mechanism of action of antioxidants and the potential benefits. The evidence for benefits and risks from the major antioxidants most commonly touted to consumers will be examined.

Understanding and Treating Schizophrenia

Sun, 15 Apr 2012 00:00:00 GMT

Schizophrenia is an often-misunderstood illness. Even those who have it do not totally understand the natue of their condition, so it can be a confusing, terrifying experience. Patients stricken with schizophrenia and their families often seek advice from their community pharmacist. In order to effectively counsel patients affected by schizophrenia, pharmacists should have a greater insight into the condition and the treatment options available for the management of schizophrenia. The program includes a review of signs and symptoms, an update of currently available treatment options for schizophrenia and strategies to educate patients and family members on drug treatment and the long-term medication and adherence problems commonly encountered

Omega-3 Fish Oil: The Role of EPA and DHA in Human Health

Thu, 30 Aug 2012 00:00:00 GMT

The benefits of increasing intake of omega-3 fish oil and possibly other good fats are heavily touted in the lay literature and on the internet. But what conditions are these "good" fats helpful for? This program will provide information on the mechanism of action of omega-3 fish oil and role of EPA and DHA in human health.

This program is NOT accredited for Florida Nurses.

Supplement Nuts and Bolts

Fri, 03 Jun 2011 00:00:00 GMT

Although supplements are big business, many pharmacists may not be comfortable recommending various ones to patients. As part of the PharmCon supplement series, this program will provide a general overview on dietary supplements. Information on regulatory issues with supplements, how to select a quality product, important drug interactions, resources for learning more, and how to report problems or adverse effects with supplements will all be covered.

The Development and Treatment of Hypothyroidism

Thu, 05 Apr 2012 00:00:00 GMT

This program will provide health care providers with the development and treatment of hypothyroidism. At the completion of this activity, the participant will be able to explain the basic thyroid structure and function outline the risks and causes for the development of hypothyroidism. Participants will also know how to describe how hypothyroidism develops, what constitutes a diagnosis of the condition, as well as explain the risks and benefits of medications for thyroid disease. Lastly, participants will know how to describe the potential side effects and considerations of prescribing medications for hyperthyroidism.

Using Behavioral Approaches to Bladder Care and Making Anticholinergics Work More Effectively

Fri, 23 Dec 2011 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding the use of behavioral control to regulate bladder and methods in making anticholinergics more effective. After completing this program, participants will be able to understand the prevalence of urinary incontinence (UI) and define urinary incontinence (UI). Next, participants will know how to describe the symptoms of OAB and understand the taboo nature of the topic of UI and the importance of physician education to enhance care. Lastly, participants will be able to determine methods of treatment for UI in patients with overactive bladder (OAB) and understand the relevance of combination therapy for OAB symptoms.

Treating Chronic Pain While Preventing Abuse and Diversion of Prescription Opioids

Thu, 08 Sep 2011 00:00:00 GMT

Healthcare providers and pharmacists in particular must ensure that they have appropriate control measures in place to minimize abuse and diversion of prescription drugs. Dispensing procedures without control and professional caution are an invitation to the drug abuser. Proper controls can be accomplished by following common sense, sound professional practice, and proper dispensing procedures. In addition, pharmacy staff should have knowledge of these safeguards, as it will help prevent and protect the pharmacy from becoming a source of diversion. This program will provide pharmacists with an overview of opioid pain medication and identify the signs of abuse and diversion that can occur with patients, family or friends. The program will emphasize the role of the pharmacist in intervening and educating patients to prevent abuse and diversion while optimizing pain management

Medicinal Fibromyalgia Treatments, Contradictions, and Side Effects

Fri, 30 Mar 2012 00:00:00 GMT

This program will provide health care providers with medicinal fibromyalgia treatments, contraindications, and side effects. At the completion of this activity, the participants will be able to describe the etiology and epidemiology of fibromyalgia. Participants will also be able to outline the American College of Rheumatology criteria for the classifications and diagnosis of a patient with fibromyalgia. Lastly, participants will know how to identify at least three current FDA approved pharmaceutical therapies used for fibromyagia to include their contraindications and side effects.

An Overview of Psoriasis: The Etiology, Common Triggers, and Current Treatment Options

Tue, 17 Jan 2012 00:00:00 GMT

This program will provide participants with an understanding of the etiology, common triggers, and current treatment options for psoriasis. After completing this program, health care professionals will understand the etiology of psoriasis and describe the five types of psoriasis and common signs and symptoms of the disease. Next, they will be able to explain typical outbreak triggers experienced by patients with psoriasis. Finally, participants will know how to discuss current treatment options based on the severity of psoriasis.

Empowering the COPD Patient: Current Treatments and Medication Adherence Optimization

Thu, 01 Mar 2012 00:00:00 GMT

Currently there are an estimated 10 million U.S. adults with physician-diagnosed COPD. Data suggests that approximately 24 million U.S. adults have evidence of impaired lung function, indicating that COPD is significantly under diagnosed. While COPD is not cureable, early diagnosis, proper treatment, and patient adherence can slow the progress of the disease. As an under diagnosed condition with low adherence rates, COPD is a very treatable condition that can be managed with effective training. For the COPD patient who is diagnosed and enrolled in a treatment plan, the pharmacist can open the maintain an ongoing dialog to ensure proper use of inhaler and other medications.

Understanding and Treating Acute Coronary Syndrome

Tue, 15 Feb 2011 00:00:00 GMT

Pharmacists can make a difference in the management and treatment of acute coronary syndrome. This program will educate healthcare providers on ACS treatment guidelines, provide an update on pharmacotherapy, and the challenges associated with ACS treatment so they can more comfortably respond to patients and providers in their role as pharmacist.

Vitamin D Benefits for Bones and Beyond: New Dosage Recommendations and Potential Uses

Tue, 28 Jun 2011 00:00:00 GMT

This program will provide participants with an understanding of new dosing and uses of Vitamin D supplements for bone health and related fields. After completing this program, pharmacists and nurses will be able to identify adequate intake Vitamin D dosages for appropriate patient populations by age for bone health. Participants will also know how to describe symptoms indicative of low and high Vitamin D levels. Lastly, participants will be able to review the potential dosages and beneficial effects of Vitamin D supplementation on cancer and heart diseases. After completing this program, pharmacy technicians will be able to in general terms, describe the potential beneficial effects of Vitamin D on bond health, cancer, and heart disease.

Treating Breakthrough Cancer Pain - What Pharmacists Need to Know

Thu, 20 Jan 2011 00:00:00 GMT

Pain is one of the most common, yet misunderstood and feared symptoms of cancer. Breakthrough cancer pain when left untreated significantly impacts quality of life. The treatments available for breakthrough cancer pain require health care providers and pharmacists in particular to pay strict attention to REMS process set up by pharmaceutical companies. This program will enhance the pharmacists' understanding of breakthrough cancer pain, provide pharmacists with an overview of the pain medications available for opioid tolerant cancer patients with breakthrough cancer pain, describe the REMS processes, delineate strategies, and mitigate the risk of abuse and misuse of these pain medications.

Parkinson's Disease Treatment

Fri, 30 Mar 2012 00:00:00 GMT

This program will provide health care providers with Parkinson's Disease treatment. At the completion of this activity, the participant will be able to describe Parkinson's Disease and list drugs used in the treatment of Parkinson's Disease. Participants will also be able to describe the pharmacological management of each drug used in the treatment of Parkinson's Disease. Lastly, participants will know how to explain the mechanism of action, toxicities, and pharmacokinetics of drugs used to treat Parkinson's Disease.

Emily's Act: An Impact on Public Safety and Medication Errors -LAW-

Fri, 15 Oct 2010 00:00:00 GMT

Emily Jerry was nearly ready to go home from a Cleveland hospital. The grapefruit-size tumor in her abdomen seemed gone, and the 2-year-old was getting one last round of chemotherapy just to make sure. Instead, a medication error killed her. A pharmacy technician mixed Emily's chemotherapy drug with a saline solution 26 times above normal. The pharmacist-on-duty was eventually convicted of involuntary manslaughter. Join us in reviewing the facts of this case that has nationwide impact and is the cause of significant changes in the pharmacy profession. Attention Florida Pharmacists & Technicians: This one hour presentation does not satisfy the medication errors requirement for the State of Florida.

Phantom Limb Pain & Phantom Limb Sensations

Mon, 06 Feb 2012 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding of the prevalence and incidence of phantom limb pain and phantom limb sensations. After completing this program, participants will be able to recognize the prevalence and impact of PLP and PLS on amputation patients. Participants will know how to identify and describe the psychological physiological mechanisms that are currently believed to be responsible for producing PLP and PLS. Participants will also know how to assess and distinguish between PLP and PLS, as well as synthesize a timely and appropriate diagnosis. Lastly, participants will be able to improve adherence to evidence-based clinical guidelines for the management of troublesome PLP and PLS in practice.

Medication Treatment Alternatives for Autism Spectrum Disorder

Thu, 25 Aug 2011 00:00:00 GMT

This knowledge based activity will provide an extensive overview of the pharmacological therapy of the associated behaviors of the autism spectrum disorders. The program will provide a brief review of information related to the pervasive development disorders. The focus will then shift to the analysis of available literature for the pharmacotherapy of the associated symptoms.

Fibromyalgia, It's Treatment, and What the Pharmacist Should Know

Thu, 23 Feb 2012 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding of a pharmacist’s role in the management of fibromyalgia. After completing this program, participants will be able to describe at least three unique characteristics, at least three symptoms, and three physical signs of fibromyalgia. Participants will know how to explain at least three classes of medications, at least two investigational classes of treatments, and at least nonpharmacological treatments for fibromyalgia. Lastly, participants will know how to describe the importance of patient education in the management of fibromyalgia, describe the prognosis of patients, and describe a stepwise approach to managing fibromyalgia.

Immunizations: An Update on HPV, Pneumococcal, and Shingle Vaccinations

Thu, 10 Nov 2011 00:00:00 GMT

The world of immunizations is quite controversial. There are many concerns about who should receive certain vaccines, and any side effects that are attributed to them. This program will go over several different vaccines, and hopefully put to rest some common misconceptions associated with them. This knowledge based program will give healthcare providers the tools needed to create a successful immunization niche.

The Use of Herbal and Dietary Supplements in the Treatment of Herpes Simplex Virus Types 1 & 2

Thu, 14 Jul 2011 00:00:00 GMT

The goal of this continuing education article is to describe the use of herbal and dietary supplements in the treatment of herpes simplex virus type 1 and type 2. At the completion of the article, participants will be able to define the epidemiology of herpes simplex virus as well as define common prescription medications for the treatment of herpes simplex virus. Participants also be able to describe common herbal and dietary supplements for the treatment of herpes simplex virus.

Discriminating Facts - Chronic Pain and Women

Thu, 15 Mar 2012 00:00:00 GMT

Healthcare professionals, including pharmacists, are often barriers to improving pain management of their patients primarily because of their lack of pain-management education and their unfounded fears and biases. Women are more likely than men to experience bias in treatment. Optimizing pain relief is crucial to helping a patient regain control of his or her life. Because pharmacotherapy plays a prominent role in treating chronic pain, it is also a perfect opportunity for the pharmacist to be involved. This program will satisfy the education need by creating a program for pharmacists that will enhance their understanding of chronic pain, identify the gender gap, pharmacotherapy, counseling points and information needed to work with the patient to reduce pain and improve quality of life.

Coenzyme Q10 Update: Who Needs It?

Fri, 17 Jun 2011 00:00:00 GMT

Coenzyme Q10 has been touted for many different conditions and diseases. These have ranged from heart failure to male infertility. With annual sales of over $200 million, this substance is frequently used by consumers. Although the data for using this antioxidant is limited, there are some conditions for which it may be useful.

Opioid and Opioid Rotation - What Pharmacists Need to Know

Sat, 01 Oct 2011 00:00:00 GMT

Because of their knowledge of opioid medications, pharmacists can provide valuable information on the most appropriate opioid for pain management and perform a comprehensive review of past and current pharmacologic interventions. There are so many reasons why switching from one opioid analgesic to another may be necessary and helpful, yet safely doing so appears to involve as much clinical art as science. This can make healthcare providers and their patients justifiably nervous, and may be a prime reason why opioids are not prescribed appropriately. What can practitioners do? This knowledge based activity will use case studies and examples to educate healthcare providers on opioid rotation and dose conversions.

A Review of Pathophysiology and Medicinal Treatment Options of Rheumatoid Arthritis

Thu, 28 Apr 2011 00:00:00 GMT

Rheumatoid arthritis (RA) is considered the most common chronic inflammatory autoimmune disease, occurring in 1 to 2% of the worldwide population1-4 However, certain ethnic groups such as Native American Indians (Pima and Chippewa) report a higher incidence, reaching approximately 5%. 1,2,5 The hallmark of rheumatoid arthritis consists of synovial joint inflammation, leading to bone and cartilage destruction. Extra-articular manifestations, including rheumatoid nodules, vasculitis, lymphadenopathy, cardiopulmonary disease and eye inflammation, may also occur.1,3 While the exact etiology is unknown, genetic predisposition in combination with environmental triggers are theorized to increase the risk for rheumatoid arthritis. Incidence increases throughout life, affecting women two to three times more often than men. Early aggressive treatment to manage symptoms and slow disease progression include disease-modifying antirheumatic drugs (DMARDs), adjunctive non-steroidal anti-inflammatory agents and corticosteroids, physical therapy, exercise and rest.1-4 This article focuses on the pathophysiology of rheumatoid arthritis, current medicinal treatment options, and side effects.

Diabetes and Dyslipidemia - What About Statins

Wed, 17 Aug 2011 00:00:00 GMT

After completing this program, pharmacists will be able to review the recent developments and outline the clinical evidence that has shaped today’s concepts of cholesterol management in diabetics. Participants will then be able to outline the benefits and limitations of statin therapy in diabetics to include mechanisms of action, efficacy, dose and side effects. Lastly, participants will know how to describe the pharmacist’s role in counseling diabetes patients on lifestyle changes, drug treatment strategies and medication adherence to improve the quality of life.

Take a Deep Breath: A Review of Medications Used for Asthma and COPD

Tue, 01 May 2012 00:00:00 GMT

For most of us, taking a deep breath is a way to relax or calm down. But for those with asthma and chronic obstructive pulmonary disease, taking a deep breath is often terrifying, and sometimes impossible. Fortunately, there are a plethora of medications that can be used to help these patients breathe a little easier. This monograph will offer insights into the pharmacological treatments for both asthma and COPD.

HIV Diagnosis & Treatment - A 25 Year Journey - FL Approved -

Thu, 29 Sep 2011 00:00:00 GMT

AIDS has killed more than 25 million people since 1981. That’s about half as many deaths as in World War II. And it's not over. 1.1 million Americans are among the 33 million people now living with HIV, the virus that causes AIDS. This knowledge based program will educate pharmacists on HIV treatment principles and current guidelines for use of antiretroviral therapy so they can more comfortably respond to HIV patients and providers in their role. The program includes information on pharmacologic treatments, patient counseling, and a question/answer period

This program is approved for by the Florida Board of Pharmacy to meet HIV/AIDS requirements in the state of Florida.

Therapies for Obesity Management

Wed, 25 Jan 2012 00:00:00 GMT

This program will provide participants with an understanding of obesity management and treatment. After completing this program, participants will be able to describe pathophysiology, epidemiology, and public health impacts of obesity. Participants will be able to recognize the causes and complications of obesity and identify nonpharmacological and pharmacological approaches to obesity management. Lastly, participants will know how to describe the mechanism of action of drugs used for obesity treatment and the adverse effects of medications used to treat obesity.

Sex Differences in Pain and Analgesia

Tue, 06 Mar 2012 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding of pain and analgesia with respects to gender. After completing this program, participants will be able to recognize the female preponderance for most chronic pain conditions and identify and describe the divergent mechanisms which drive sex differences in pain and analgesia. Participants will also know how to evaluate the impact of specific biological, psychological, and socio-cultural factors that influence sex differences in pain perception. Lastly, participants will be able to better understand how and why females react differently than males to opioids and other analgesics.

Current Prevention and Treatment Strategies for Influenza

Fri, 05 Aug 2011 00:00:00 GMT

This program will provide pharmacists, pharmacy technicians, and nurses with an understanding of current prevention and treatment strategies for influenza. After completing this program, pharmacists and nurses will be able to describe the epidemiology of influenza and identify the various pharmaceutical options for the prevention of influenza to include the ease of use, comparative efficacy, and contraindications of vaccines. Pharmacists and nurses will also be able to describe the pharmacist’s role in the prevention and treatment of influenza. Pharmacy technicians will be able to describe the signs and symptoms of the flu and identify the medications used to treat the flu.

Safety Measures for Prescription Labeling: 21st Century Best Practices

Tue, 17 Apr 2012 00:00:00 GMT

At the completion of this activity, participants will be able to discuss patient literacy as a barrier to understanding prescription label instructions and list items required on a prescription label by the FDA or state boards of pharmacy. Participants will also be able to identify aspects of existing medication labels that prevent clear understanding of directions or reasons for use. Lastly, participants will know how to describe at least four changes to medication labels that can improve clarity and reduce errors, which include a discussion of relatively recent initiatives (e.g., ClearRx).

Veterans and Chronic Pain- A Growing Population

Tue, 31 Jul 2012 00:00:00 GMT

Since October 2001, approximately 1.6 million members of the Armed Forces have served in Iraq or Afghanistan. Moreover, we have more than 20 million veterans of military service in the United States today. Now more than ever, pharmacists are likely to encounter veterans of our military suffering from chronic pain in the community setting. Pain is a major driver for visits to physicians, a major reason for taking medications, a major cause of disability, and a key factor in quality of life and productivity in our veteran population. This activity will focus on the current state of chronic pain management with a focus on our veteran population and the different challenges pharmacists may face when dealing with the veteran population.

Pharmacology in Thyroid Conditions

Tue, 13 Mar 2012 00:00:00 GMT

This program will provide participants with an understanding of pharmacology in thyroid conditions. After completing this program, participants will be able to explain the pathway of thyroid hormone synthesis as a basis in the understanding of the mechanism of action of the thyroid and anti-thyroid medications. Participants will know how to explain the pathophysiology of thyroid problems and be able to list the different medications that are being used clinically for the treatment of thyroid conditions. Next, participants will be able to describe and demonstrate the uses of the thyroid and antithyroid medications in the clinical setting as well as describe the mechanism of action of the drugs used in the treatment of thyroid problems. Lastly, participants will be able to explain the adverse the effects of the drugs used in treating thyroid problems and correlate the knowledge gained from this monograph in clinical practice.

A Pharmacist's Role in the Management of Prescription Drug Abuse

Thu, 01 Dec 2011 00:00:00 GMT

Prescription drug abuse is rapidly becoming one of the most serious and critical public health concerns in this country. Numerous initiatives have been implemented by federal and state legislators in an attempt to curtail this crisis. Many of these have focused on educating physicians about sound narcotic prescribing practices; however, few have explored the potential benefit of utilizing the pharmacist to help combat this dilemma. Since pharmacists are frontline health care providers, it is imperative that they receive the education and training to respond appropriately to this growing problem. Instructing pharmacists on how to identify, manage, and prevent prescription drug abuse has the potential to be one of the most effective methods in dealing with this issue.The focus of this article is on the enormous consequences that prescription drug abuse has had in the United States in recent years, and the pivotal role that pharmacists can have in easing this burden.

The Reality of Adolescent Depression

Mon, 06 Dec 2010 00:00:00 GMT

This program promotes the need for increased awareness of depression in adolescents. About 20 percent of teens will experience teen depression before they reach adulthood. Less than 33 percent of teens with depression get help, yet 80 percent of teens with depression can be successfully treated if they seek help from a doctor or therapist, and many local health clinics offer free or discounted treatment for teens with depression. This program is designed to assist pharmacists in understanding Major Depressive Disorder (MDD), especially in adolescents, as well as the benefits of managing this disorder with medications. The program includes information on pharmacologic treatments, drug interactions, and patient counseling.

Haunted Minds- The Nightmare of Schizophrenia

Thu, 17 Jan 2013 00:00:00 GMT

Patients with schizophrenia that consistently take their medication are much less likely to be hospitalized, usually behave less aggressively and have a much better quality of life. The very nature of schizophrenia can complicate treatment. Consistency is the key for successful treatment. But people with schizophrenia have a hard time sticking to routines. An effective medication regimen for schizophrenia requires more than just initial treatment; continuous follow up is often necessary to ensure both compliance and adherence. Whether counseling patients face to face or on the phone, contacting adherence. Whether counseling patients face to face or on the phone, contacting patients that don't refill prescriptions and/or checking for harmful side effects or interactions, pharmacists can play a key role in the effective treatment of schizophrenia. This knowledge based activity offers pharmacists and a nurses a basic understanding of schizophrenia, reviews currently available treatment for schizophrenia and describes strategies to overcome challenges with medication non-adherence and compliance.

Taking Control of T2DM: The Role of Incretin Mimetics in Improving Outcomes

Wed, 23 Jan 2013 00:00:00 GMT

This knowledge-based program will assist pharmacists in understanding the intricacies of treating diabetes, so as to provide excellent comprehensive information and care for the patients, throughout the entirety of care. The presentation will provide a review of both current and novel treatment options for the management of diabetes, as well as motivational counseling techniques to encourage adherence for the T2DM patient. The program includes information on pharmacologic treatments, patient counseling and education..

Joint Supplements

Fri, 08 Jul 2011 00:00:00 GMT

This program will help pharmacists sort through the hype related to various joint supplements. This program will provide information on the efficacy of various dietary supplements for improving joint function and decreasing pain related to osteoarthritis. This program will provide information on glucosamine, chondroitin, shark cartilage, and other agents for joint health.

Medication Errors and Public Safety: Tragic Consequences When the System Breaks Down -FL APPROVED/LAW

Mon, 16 May 2011 00:00:00 GMT

To provide pharmacists with an understanding of pharmacy dispensing errors, including causes, prevention, and the legal issues resulting from these errors.
This is approved for FL Medication Errors Credit.

Protecting Your Practice - Tackling Prescription Drug Abuse

Wed, 16 May 2012 00:00:00 GMT

Prescription drug abuse is one of the most serious and critical public health concerns in the country. Numerous initiatives have been implemented by federal and state legislators in an attempt to curtail this crisis. Many of these have focused on educating physicians about sound narcotic prescribing practices; however, few have explored the potential benefit of using the pharmacist to help combat this growing problem. Since pharmacists are frontline health care providers and the provider that actually fills the prescription, it is imperative that they receive the education and training to proactively work with patients and prescribers to identify, manage, and prevent prescription drug abuse. This knowledge based program will focus on the enormous consequences that prescription drug abuse has had in the United States in recent years, and the pivotal role that pharmacists can play in addressing this growing problem.

Chronic Pain in the Golden Years - Aging Gracefully or Suffering in Silence

Sat, 15 Oct 2011 00:00:00 GMT

Seniors are particularly vunerable to chronic pain. As we age, our bodies go through intense changes. Optimizing pain relief is crucial to helping an aging patient regain or maintain control of his or her life. Because pharmacotherapy plays a prominent role in treating chronic pain, it is also a perfect opportunity for the pharmacist to be involved. This program will satisfy the education need by creating a program for pharmacists that will enhance their understanding of chronic pain, the challenges associated with treating an aging population, pharmacotherapy, counseling points, and information needed to work with the patient to reduce pain and improve quality of life.

Current Treatments for Restless Legs Syndrome

Wed, 15 Feb 2012 00:00:00 GMT

After completing this program, participants will be able to describe the symptoms of restless leg syndrome and outline the factors involved in a differentials diagnosis of restless leg syndrome. Participants will know how to review non-pharmacologic and behavioral treatments for mild RLS symptoms and differentiate between treatments for secondary RLS and those for primary RLS. Next participants will be able to list first-line medications for moderate to severe symptoms and understand augmentation and rebound effects with certain medications. Lastly, participants will know to list medications that are appropriate for mild or intermittent RLS symptoms.

When Pain Relief Leads to Pain Medication Abuse-Pharmacists Intervene

Sat, 01 Jan 2011 00:00:00 GMT

This knowledge-based program will assist pharmacists in understandingthe facets of pain felt by patients, and the justifications patients may give for abusing pain medications. The program is designed to enhance pharmacists' knowledge of available information for these patients, and includes information on elements of pharmacologic treatments and patient counseling.

Common Indications for Anticoagulation and Their Medicinal Treatments

Wed, 25 Jan 2012 00:00:00 GMT

This program will provide nurses and pharmacists with an understanding of anticoagulation and medicinal treatment. After completing this program, participants will be able to list common indications for anticoagulation and understand as well as describe the mechanism of thromboembolism for each indication. Participants will also know how to explain the traditional risk factors and the current anticoagulant treatment guidelines for each indication. Finally, participants will be able to list the commonly used anticoagulants, their side effects, dosage forms and schedules, and understand each anticoagulant’s ability for rapid reversal.

Schizophrenia and Weight Gain - Strategies to Improve Adherence

Thu, 01 Dec 2011 00:00:00 GMT

Independent of medication, schizophrenia always has been associated with weight gain. Up to 50% of patients taking antipsychotics gain weight. Additionally, weight gain is associated with non adherence, relapse and decreased quality of life. This program will give pharmacists an understanding of the underlying conditions, potential of currently available treatment options (along with their probable results and possible side effects) and the need to educate patients and family members on drug treatment strategies and the long-term medication adherence problems commonly encountered with schizophrenia.

The Pathophysiology and Pharmaceutical Treatment of Chronic Hepatitis

Fri, 30 Mar 2012 00:00:00 GMT

After the completion of this monograph, the reader should be able to understand the pathophysiology of chronic hepatitis, its incidence and prevalence, its primary symptoms and main risk factors, and be able to identify the most commonly used pharmaceuticals and their potential side effects.

Contraception

Mon, 30 Apr 2012 00:00:00 GMT

A the completion of this monograph, the participant will be able to explain the physiology and the normal hormonal changes int he menstrual cycle as a basis for understanding the mechanism of action for different contraceptive methods. Participants will also know how to list the different methods and drugs that are being used clinically for contraception and describe the mechanism of action of the methods and medications used for contraception. Participants will also be able to describe the advantages and disadvantages of the different contraceptive methods, and determine the appropriate method to be used in certain clinical situations. Lastly, participants will be able to describe the proactive role that pharmacists can play in counseling patients on the proper use of contraception.

Reducing the Risk of Stroke in Patients with Atrial Fibrillation

Mon, 01 Aug 2011 00:00:00 GMT

Approximately 75,000 strokes occur each year in the United States in patients with atrial fibrillation. Current guidelines recommend oral anticoagulation for high-risk patients with atrial fibrillation, but the inherent limitations of these agents lead to substantial underuse. This state of affairs has stimulated the development of new agents with improved benefit-risk profiles, which appear to be offer a wider therapeutic margin and low potential for drug interactions, allowing more convenient dosing without anticoagulation monitoring. Pharmacists must understand the underlying condition, possible comorbid conditions, potential of currently available treatment options (along with their probable results and possible side effects) and play an active role in educating patients on their drug treatment strategies and lifestyle changes necessary to reduce the risk of stroke in atrial fibrillation.

The Pathophysiology and Pharmaceutical Treatment of Hypertension

Fri, 30 Dec 2011 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding of the Pathophysiology and Pharmaceutical Treatment of Hypertension. After completing this program, participants will be able to understand the prevalence and incidence of hypertension. Participants will also understand the pathophysiology, primary symptoms and main risk factors of hypertension. Lastly, participants will be able to identify the most commonly used pharmaceuticals and their potential side effects.

Three Generations: The Past, Present, and Future of Transdermal Drug Delivery Systems

Mon, 16 May 2011 00:00:00 GMT

For thousands of years, human civilizations have applied substances to the skin as cosmetics and medical agents. However, it was not until the twentieth century that the skin came to be used as a drug delivery route. While there are many advantages to transdermal drug delivery, the disadvantages include a set of specific molecular properties for delivery and possible patient concerns with this method of delivery. Prausnitz and Langer define three generations of transdermal drug delivery systems: first generation, which encompasses the typical patch technology widely available at present; second generation, which seeks to enhance the penetration of first generation molecules; and third generation, which uses novel technologies to deliver a wide range of molecules across the skin. This presentation will examine the science of transdermal drug delivery, review the FDA-approved products in each generation, and introduce the pharmacists to new technologies that have the potential to impact the pharmacy practice in the future.

Vitamin D and Calcium Supplements

Sun, 10 Jul 2011 00:00:00 GMT

Lots of new benefits of vitamin D are being touted and many Americans are vitamin D deficient. There is significant controversy on how much vitamin D is necessary for various groups of patients. Because similar issues occur with calcium supplements, recommending these supplements can also be a complicated issue. This program will help pharmacists recommend appropriate vitamin D and calcium supplements.

Treating Chronic Pain - The Art and Science of Opioid Therapy and Rotation

Tue, 07 Aug 2012 00:00:00 GMT

There are many reasons why switching from one opioid analgesic to another may be necessary and helpful, yet safely doing so appears to involve as much clinical art as science. This can make healthcare providers and their patients justifiably nervous, and may be a prime reason why opioids are not always prescribed appropriately. What can practitioners do? This knowledge based activity will use case studies and examples to educat health care providers on both the art and science of opioid treatment and rotation for chronic pain.

Osteoporosis Update: Adding New Tools and Treatments to Disease Management

Tue, 22 Nov 2011 00:00:00 GMT

This program will provide participants with an understanding of new tools and treatments for disease management in osteoporosis. After completing this program, participants will be able to describe the bone remodeling imbalance that occurs in osteopenia and osteoporosis. Participants will know how to use existing clinical tools (eg, T score, new FRAX algorithms) to identify osteoporosis risk and to evaluate disease management options. Participants will also know how to discuss concerns with bisphosphonates, the current first-line treatment options and differentiate mechanisms and dosing methods of new osteoporosis drug classes from standard treatments. Lastly, participants will be able to select populations who would most benefit from treatment with new and emerging medications.

Review of Federal and Controlled Substance Laws: Part 2

Thu, 14 Feb 2013 00:00:00 GMT

This knowledge based activity will review the requirements under federal law for a controlled substance inventory, what to do when a controlled substance is spilled or breakage occurs, and other common problems with dealing with recalls and mailing of controlled substances. The information provided is based on the Federal Controlled Substance Act. Some of the information may be different in different states. States can make their own laws more restrictive than federal law, but not less restrictive. All questions regarding the practice of pharmacy should be directed to the Board of the Pharmacy in the state where the pharmacist practices.

Review of Federal and Controlled Substance Laws: Part 1

Thu, 14 Feb 2013 00:00:00 GMT

This knowledge based activity will review the concept of corresponding responsibility, common legal issues when dispensing controlled substances, and identify legal requirements specific to schedule II controlled substances. The information provided is based on the Federal Controlled Substance Act. Some of the information may be different in different states. States can make their own laws more restrictive than federal law, but not less restrictive. All questions regarding the practice of pharmacy should be directed to the Board of the Pharmacy in the state where the pharmacist practices.

Types of Diarrhea and Management Strategies

Fri, 03 Jun 2011 00:00:00 GMT

This program will provide participants with an understanding of current types of diarrhea and management strategies. After completing this program, nurses and pharmacists will be able to state the difference between acute and chronic diarrhea and differentiate between secretory diarrhea, osmitic diarrhea and motility disorders. Pharmacists and nurses will also be able to review the classifications of drugs used to treat diarrhea. After completing this program, pharmacy technicians will be able to in general terms, describe the signs and symptoms of diarrhea and identify the medications used to treat diarrhea.

Head Lice Treatment Options Today

Tue, 28 Jun 2011 00:00:00 GMT

This program will provide pharmacists, nurses, and pharmacy technicians with an understanding of head lice treatment options today. After completing this program, pharmacists and nurses will be able to describe the life cycle of head lice (pediculosis captitis), explain the issues involved in ensuring an accurate diagnosis of an active head lice infestation, and state the use of the non-prescription and prescription only pediculicides and their warnings. After completing this program, pharmacy technicians will be able in general terms, describe the life cycle of head lice and identify the medications used to treat head lice.

New Treatment Considerations for Type 2 Diabetes Mellitus

Fri, 16 Dec 2011 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding of new treatment considerations for type two diabetes mellitus. After completing this program, participants will know how to explain the morbidity and mortality risks associated with the epidemic of type two diabetes mellitus in the United States and identify goals of treatment and means of monitoring patients to evaluate treatment efficiency. Participants will also be able to outline supportive care best practices that can improve quality of life and prevent chronic morbidity. Lastly, participants will know how to compare the mechanisms, dosages, and adverse events of DPP-4 inhibitors, a class of new antidiabetes drugs, with standard treatment options.

The Pathophysiology and Pharmaceutical Treatment of Chronic Bronchitis

Wed, 01 Feb 2012 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding of the prevalence and incidence of chronic bronchitis. After completing this program, participants will be able to understand the pathophysiology chronic bronchitis and be able to describe its primary symptoms and main risk factors. Participants will also know how to explain the epidemiology and etiology of chronic bronchitis as well as identify the most commonly used pharmaceuticals and their potential side effects.

Urinary Incontinence - An Epidemic?

Tue, 09 Aug 2011 00:00:00 GMT

Urinary Incontinence is a significant global, social and public health concern and the leading cause of long term care facility placement in the United States, affecting 50% of nursing home residents. Many myths surround this disease as well as its diagnosis and management. The healthcare professional's knowledge of urinary incontinence and their willingness to discuss it is vital for a patient's diagnosis and subsequent treatment. It is a common misconception that incontinence is a normal part of aging and is something that must be lived with. There are many treatment options available and are not all surgical.

Intermittent Androgen Deprivation Therapy for Treatment of Prostate Cancer – What are the Benefits?

Fri, 05 Aug 2011 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding of Androgen Therapy and its relation to Prostate Cancer treatment. After completing this program, participants will be able to review the etiology and epidemiology of prostate cancer, outline the types of androgen deprivation therapy, and describe androgen deprivation therapy to include mechanism of action, side effects and means to mitigate the side effects.

Treatment Resistant Depression: Challenges in Care for Hispanic Americans

Wed, 15 May 2013 00:00:00 GMT

Major depressive disorder is a severe and pervasive condition that requires a complex and strategic balance of approaches for treatment. While this condition is present in a variety of populations, some are particularly hard hit. As of 2012, Hispanics are now the largest minority group in the United States, constituting over 16% of the population. The American Psychiatric Association has found that older Hispanic adults and younger Hispanic youth are especially vulnerable to MDD due to the pressures of acculturation after immigration. In order to prevent Hispanics from suffering silently with MDD or TRD, we must focus adequate attention on overcoming barriers specific to their population. This presentation will detail the unique challenges of the Hispanic population and current trends in the pharmacologic treatment of depression, focusing on Treatment Resistant Depression.

Treating Chronic Pain - Opioid Analgesics

Mon, 03 Oct 2011 00:00:00 GMT

The June 29, 2011 report titled: Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research from the Institute of Medicine offers many insights into pain management. Pain is a major driver for visits to physicians, a major reason for taking medications, a major cause of disability, and a key factor in quality of life and productivity. Given the burden of pain in human lives, dollars, and social consequences, relieving pain should be a national priority. This activity will focus on the current state of chronic pain management, the continued need for opioid analgesics, and how these issues speak to the pharmacist working in the community setting.

Autoimmune Disease Control: New Treatments for Old Problems

Fri, 02 Sep 2011 00:00:00 GMT

This program will provide participants with an understanding of autoimmune disease control and new methods being employed. After completing this program, participants will be able to discuss shared symptoms, markers, and disease progression of autoimmune diseases. Participants will be able to explain the immune-suppressing mechanisms and risks of belimumab and tolicizumab. Health care professionals will also be able to describe the appropriate patient who should receive belimumab for treatment of systemic lupus erythematosus (SLE). They will be able to discuss to explain the etiology of systemic juvenile idiopathic arthritis (SJIA) and the benefits of tolicizumab on the disease symptoms. Finally, after completing the program, participants will be able to identify the symptoms of Restless legs syndrome (RLS), and the benefits of gabapentin enacarbil versus traditional RLS therapies.

Women at Risk: Anticoagulation Issues in Atrial Fibrillation

Sun, 15 Apr 2012 00:00:00 GMT

Currently, it is estimated that approximately 2.3 million US adults have atrial fibrillation, which increases risk of stroke and accounts for 1/6 of all strokes in the US. Although equal numbers of men and women are currently diagnosed with AF, studies have shown that female atrial fibrillation patients have a higher rate of stroke and death than men, with women accounting for nearly 2/3 of stroke-related deaths. Additionally, women frequently differ from men in their atrial fibrillation presentation and medical co-morbidities. In order to properly oversee female AF patients, pharmacists need to be updated on recent research about existing and novel anticoagulants, the signs and symptoms specific to omen that would require intervention, and beneficial treatment options for women which may have previously been overlooked.

Liver Disorders: Diagnosis, Treatment, and Acetaminophen Associated Hepatotoxicity

Fri, 16 Sep 2011 00:00:00 GMT

This program will provide participants with an understanding of liver disorders, their diagnosis, treatment options, and acetaminophen associated hepatotoxicity. After completing this program, participants will be able to identify the three major physiologic functions of the liver. Next, participants will be able to list and define common presentations associated with liver disease and explain the mechanism of acetaminophen-induced hepatotoxicity. Participants given an actual or simulated case of a patient with liver disease, they will be able to determine the severity classification after the presentation. Participants will also know how to recognize medications that require dosage adjustment in patients with liver dysfunction and provide dosing recommendations based on the severity of disease. Lastly, participants will know how to develop a regimen to treat a patient with acetaminophen-induced hepatotoxicity.

Diabetes: The Treatment

Mon, 02 Apr 2012 00:00:00 GMT

The second presentation in a four-part series will address the non-pharmacologic and pharmacologic management of diabetes. All medications and medication classes used to treat diabetes will be covered as well as each medication's place in therapy based on guidelines and existing evidence. In addition, lifestyle modifications and other-nonpharmacological therapies will be presented.

Acute and Prophylactic Treatments for Migraine Headache

Thu, 08 Mar 2012 00:00:00 GMT

This program will provide an understanding of treatments for migraine headaches After completing this program, health care professionals will be able to identify the pathophysiology of migraines and describe the symptoms and criteria for a migraine headache and migraine diagnosis. Next, participants will be able to outline the non-pharmacologic and behavioral therapies that may treat or prevent migraines. Finally, participants will know to how describe the first line treatments for migraines as well as outline the first-line prophylactic treatments for migraines.

But I Don't Want to Take My Medicine!

Tue, 25 Sep 2012 00:00:00 GMT

Giving a sick child medicine can sometimes be a nightmare for parents and children. What can the pharmacist do to help? This knowledge based monograph gives pharmacists a quick reference guide to improve the taste of medication and/or offer parents options to make medicine more palatable for their children.

This program was written by Joanna G. Yala, Donna Hynh, & Jill A. Morgan (pharmacy students at the University of Maryland) and edited by Lynn McPherson, Professor and Vice Chair, Department of Pharmacy Practice and Science, University of Maryland in support of the Maryland Pharmacists Association.

Old Wine in New Bottles: A Review of Current ADHD Treatments

Mon, 07 Nov 2011 00:00:00 GMT

This program will provide participants with an understanding of current ADHA treatments and their relations to older methods. After completing this program, pharmacists and nurses will be able to outline the percentage of children and adults receiving medication for ADHD. Pharmacists and nurses will know how to describe the two basic groups of medications used to treat ADHA to include the mechanisms of actions and common side effects associated with the most frequently used medications. Lastly, pharmacists and nurses will know how to identify at least one new drug used to treat ADHD (introduced to the market in the past year). Pharmacy technicians will know how to in general terms, describe the number of people being treated for ADHD and outline the two basic groups of medication used to treat ADHD.

The Role of Medication Reconciliation in Ensuring Patient Safety

Thu, 14 Jul 2011 00:00:00 GMT

The goal of this continuing education article is to describe the importance of medication reconciliation in ensuring patient safety for the intended audience of pharmacists. After completing this program, participants will be able to describe the characteristics that medication reconciliation processes used in various health care settings should include. Participants will also be able explain methods of overcoming challenges related to medication reconciliation. Lastly, participants will be able to identify the role of the pharmacists in medication reconciliation (Pharmacist Only).

Treatments for Tension Headache and Chronic Daily Headache

Fri, 30 Mar 2012 00:00:00 GMT

The presentation will provide health care providers treatments for tension headaches and chronic daily headaches. At the completion of this activity, participants will be able to describe the current knowledge of the pathophysiology of tension-type and chronic daily headache. Participants will be able to explain the symptoms of an episodic tension-type headache (TTHA) and be able to list the criteria for TTHA and chronic daily headache. Pharmacists and nurses will know how to describe non-pharmacologic and behavioral therapies that may treat or prevent headaches as well as describe the causes and management of medication overuse headache. Lastly, participants will be able to list first-line acute and first line prophylactic treatments for headaches.

It's all Greek to Me-Translating the Benefits of Lipid Lowering Therapy to your Patients

Thu, 17 Mar 2011 00:00:00 GMT

It is estimated that 50% of patients who start on cholesterol lowering medications discontinue them within 6 months! This program will give you practical information on how to translate the benefits and the risks of cholesterol lowering interventions (nonpharmacologic and pharmacologic) to patients to improve adherence and persistence. Specific ways pharmacists can improve the treatment of lipid disorders will be discussed.

Overview of Bisphosphonates and Osteoporosis

Thu, 01 Mar 2012 00:00:00 GMT

This program will provide pharmacists and nurses with an understanding of Osteoporosis and Bisphosphonates. After completing this program, pharmacists and nurses will be able to describe the modeling process that occurs in bone and identify the current indications and doses of bisphosphonates for osteoporosis to their patients. Pharmacists and nurses will also be able to outline the risk factors of osteoporotic fractures and current screening guidelines for patients as risk.

When the Going Gets Tough: The Pharmacist's Role in Managing Treatment Depression

Mon, 28 Jan 2013 00:00:00 GMT

This knowledge-based program will assist pharmacists in understanding the intricacies of treating treatment resistant depression (TRD), so as to provide excellent comprehensive information and care for the patients, throughout the entirety of care. The presentation will provide a review of both current and novel treatment options for the management of TRD, as well as educate the pharmacist on motivational counseling techniques specific to TRD patients. The program includes information on pharmacologic treatments, patient counseling and education.

Understanding and Treating Hemophilia - What Pharmacists Need to Know

Thu, 15 Dec 2011 00:00:00 GMT

Pharmacists can play a pro-active role in the treatment of hemophilia, but must understand the disease and the latest advances in pharmacotherapy. Pharmacists are often the medical professional that patients reach out to for the latest in drug information. This continuing education course gives the pharmacist a solid knowledge base to enlighten the patients on therapies with an emphasis on the need for medication adherence, counseling, drug contraindications, and general safety issues.

Taking the Mystery Out of Fibromyalgia

Thu, 01 Sep 2011 00:00:00 GMT

Fibromyalgia is a chronic, musculoskeletal, non-inflammatory pain disorder. Patients frequently suffer from sleep disturbances, headaches, anxiety, morning stiffness, and a poor sense of well-being. In many cases, it takes years to properly diagnose fibromyalgia. Pharmacists can play a key role in treating patients with fibromyalgia. They can provide valuable counseling on topics such as lifestyle modifications and treatment options for fibromyalgia. Simple changes can often lead to considerable symptom improvement. Once fibromyalgia has been diagnosed, the pharmacist can provide counseling about managing comorbidities, drug contraindications, and general safety issues.

Nutritional Support for Metabolic Syndrome with Berberine

Thu, 25 Oct 2012 00:00:00 GMT

Berberine is an alkaloid present in a number of plants, including Berberis vulgaris (European barberry), Berberis aristata (tree turmeric or Indian barberry), Berberis aquifolium (Oregon grape), Hydrastis canadensis (goldenseal), and Coptis chinensis (goldthread). In nutritional practice and therapy, berberine has been most well-known for its antimicrobial activity (against bacteria, viruses, protozoans, helminthes, fungi, and Chlamydia). Over the past few years there has been increasing interest in berberines pleotropic profile, its ability to influence a positive effect on metabolic syndrome including blood-sugar management, lipid lowering, insulin sensitivity, cardiac support, and weight management.

Drug Prescribing for the Older Adults - What the Pharmacist Should Know

Mon, 13 Feb 2012 00:00:00 GMT

After completing this program, pharmacists and nurses will be able to identify at least three of the unique challenges that arise from prescribing to older patients and outline at least two “Quality of Drug Prescribing” measures. Participants will then know to describe polypharmacy and its consequences and identify the classes of prescription medication, OTC medications, and herbal medications that are inappropriate. Next, participants will know how to explain the Beers Criteria and the adverse drug reactions and how they can prevented. Lastly, pharmacists and nurses will know how to identify steps toward safer prescribing practices.